Bain Capital Life Sciences Investors, LLC Long-Term Concentrated

CIK: 0001703031 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 15, 2022

Total Value ($000): $852,695 (100.0% shares, 0.0% debt)

Holdings (35)

— SPRINGWORKS THERAPEUTICS INC 13.9%

Value ($000) $118,947 Shares 4,831,307 Est. Cost $21.68 Unrealized —

— DYNAVAX TECHNOLOGIES CORP 12.4%

Value ($000) $105,945 Shares 8,415,000 Est. Cost $9.83 Unrealized —

PHVS PHARVARIS N V 8.2%

Value ($000) $70,291 Shares 3,180,601 Est. Cost $31.46 Unrealized -40.8%

ARQT ARCUTIS BIOTHERAPEUTICS INC 7.5%

Value ($000) $63,930 Shares 3,000,000 Est. Cost $26.87 Unrealized -23.7%

— EQRX INC 5.5%

Value ($000) $46,917 Shares 10,003,573 Est. Cost $6.82 Unrealized —

NUVL NUVALENT INC 5.5%

Value ($000) $46,484 Shares 3,428,014 Est. Cost $29.01 Unrealized -63.5%

CRNX CRINETICS PHARMACEUTICALS IN 5.0%

Value ($000) $42,999 Shares 2,305,558 Est. Cost $18.69 Unrealized +6.8%

— MERSANA THERAPEUTICS INC 4.7%

Value ($000) $40,026 Shares 8,663,673 Est. Cost $12.65 Unrealized —

AMLX AMYLYX PHARMACEUTICALS INC 4.4%

Value ($000) $37,523 Shares 1,948,214 Est. Cost $22.45 Unrealized -47.1%

RPID RAPID MICRO BIOSYSTEMS INC 4.3%

Value ($000) $36,269 Shares 8,434,560 Est. Cost $20.66 Unrealized -77.5%

— CARA THERAPEUTICS INC 2.8%

Value ($000) $24,171 Shares 2,647,473 Est. Cost $9.13 Unrealized —

NRIX NURIX THERAPEUTICS INC 2.7%

Value ($000) $23,096 Shares 1,822,883 Est. Cost $21.10 Unrealized -46.3%

— 2SEVENTY BIO INC 2.2%

Value ($000) $18,597 Shares 1,408,901 Est. Cost $18.15 Unrealized —

PTGX PROTAGONIST THERAPEUTICS INC 2.1%

Value ($000) $17,881 Shares 2,260,572 Est. Cost $12.09 Unrealized 0.0%

SVRA SAVARA INC 2.1%

Value ($000) $17,666 Shares 11,622,598 Est. Cost $1.49 Unrealized -11.6%

AVIR ATEA PHARMACEUTICALS INC 2.1%

Value ($000) $17,648 Shares 2,485,638 Est. Cost $32.23 Unrealized -78.8%

CCCC C4 THERAPEUTICS INC 1.5%

Value ($000) $12,382 Shares 1,642,210 Est. Cost $29.00 Unrealized -69.7%

ANNX ANNEXON INC 1.4%

Value ($000) $12,221 Shares 3,241,628 Est. Cost $23.46 Unrealized -87.0%

— RESEARCH ALLIANCE CORP II 1.1%

Value ($000) $9,800 Shares 1,000,000 Est. Cost $10.25 Unrealized —

TNGX TANGO THERAPEUTICS INC 1.0%

Value ($000) $8,706 Shares 1,921,790 Est. Cost $11.99 Unrealized -49.5%

ACAD ACADIA PHARMACEUTICALS INC 1.0%

Value ($000) $8,461 Shares 600,523 Est. Cost $18.68 Unrealized 0.0%

XLO XILIO THERAPEUTICS INC 1.0%

Value ($000) $8,192 Shares 2,805,413 Est. Cost $17.03 Unrealized -77.8%

— MARINUS PHARMACEUTICALS INC 0.8%

Value ($000) $6,926 Shares 1,431,058 Est. Cost $15.48 Unrealized —

— ARYA SCIENCES ACQU CORP IV 0.8%

Value ($000) $6,867 Shares 700,000 Est. Cost $10.47 Unrealized —

IVVD ADAGIO THERAPEUTICS INC 0.7%

Value ($000) $6,354 Shares 1,937,207 Est. Cost $37.11 Unrealized -91.6%

— SYROS PHARMACEUTICALS INC 0.7%

Value ($000) $6,031 Shares 6,264,420 Est. Cost $10.27 Unrealized —

NAUT NAUTILUS BIOTECHNOLOGY INC 0.6%

Value ($000) $5,380 Shares 2,000,000 Est. Cost $10.83 Unrealized -65.6%

— APTINYX INC 0.6%

Value ($000) $4,961 Shares 8,891,758 Est. Cost $8.16 Unrealized —

— SOLID BIOSCIENCES INC 0.6%

Value ($000) $4,882 Shares 7,929,918 Est. Cost $7.99 Unrealized —

— PANACEA ACQUISITION CORP II 0.6%

Value ($000) $4,880 Shares 500,000 Est. Cost $10.02 Unrealized —

— ARYA SCIENCES ACQUISITN CORP 0.6%

Value ($000) $4,860 Shares 500,000 Est. Cost $9.88 Unrealized —

— BCLS ACQUISITION CORP 0.6%

Value ($000) $4,826 Shares 487,500 Est. Cost $11.14 Unrealized —

— FRAZIER LIFESCIENCES ACQU CO 0.3%

Value ($000) $2,961 Shares 300,000 Est. Cost $10.38 Unrealized —

— X4 PHARMACEUTICALS INC 0.3%

Value ($000) $2,914 Shares 3,019,540 Est. Cost $7.84 Unrealized —

— AEGLEA BIOTHERAPEUTICS INC 0.3%

Value ($000) $2,701 Shares 5,347,689 Est. Cost $5.13 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	SPRINGWORKS THERAPEUTICS INC	4,831,307	$118,947	13.9%	$21.68	—	COM	85205L107
—	DYNAVAX TECHNOLOGIES CORP	8,415,000	$105,945	12.4%	$9.83	—	COM NEW	268158201
PHVS	PHARVARIS N V	3,180,601	$70,291	8.2%	$31.46	-40.8%	COM	N69605108
ARQT	ARCUTIS BIOTHERAPEUTICS INC	3,000,000	$63,930	7.5%	$26.87	-23.7%	COM	03969K108
—	EQRX INC	10,003,573	$46,917	5.5%	$6.82	—	COM	26886C107
NUVL	NUVALENT INC	3,428,014	$46,484	5.5%	$29.01	-63.5%	COM	670703107
CRNX	CRINETICS PHARMACEUTICALS IN	2,305,558	$42,999	5.0%	$18.69	+6.8%	COM	22663K107
—	MERSANA THERAPEUTICS INC	8,663,673	$40,026	4.7%	$12.65	—	COM	59045L106
AMLX	AMYLYX PHARMACEUTICALS INC	1,948,214	$37,523	4.4%	$22.45	-47.1%	COM	03237H101
RPID	RAPID MICRO BIOSYSTEMS INC	8,434,560	$36,269	4.3%	$20.66	-77.5%	CLASS A COM	75340L104
—	CARA THERAPEUTICS INC	2,647,473	$24,171	2.8%	$9.13	—	COM	140755109
NRIX	NURIX THERAPEUTICS INC	1,822,883	$23,096	2.7%	$21.10	-46.3%	COM	67080M103
—	2SEVENTY BIO INC	1,408,901	$18,597	2.2%	$18.15	—	COMMON STOCK	901384107
PTGX	PROTAGONIST THERAPEUTICS INC	2,260,572	$17,881	2.1%	$12.09	0.0%	COM	74366E102
SVRA	SAVARA INC	11,622,598	$17,666	2.1%	$1.49	-11.6%	COM	805111101
AVIR	ATEA PHARMACEUTICALS INC	2,485,638	$17,648	2.1%	$32.23	-78.8%	COM	04683R106
CCCC	C4 THERAPEUTICS INC	1,642,210	$12,382	1.5%	$29.00	-69.7%	COM STK	12529R107
ANNX	ANNEXON INC	3,241,628	$12,221	1.4%	$23.46	-87.0%	COM	03589W102
—	RESEARCH ALLIANCE CORP II	1,000,000	$9,800	1.1%	$10.25	—	COM CL A	760873109
TNGX	TANGO THERAPEUTICS INC	1,921,790	$8,706	1.0%	$11.99	-49.5%	COM	87583X109
ACAD	ACADIA PHARMACEUTICALS INC	600,523	$8,461	1.0%	$18.68	0.0%	COM	004225108
XLO	XILIO THERAPEUTICS INC	2,805,413	$8,192	1.0%	$17.03	-77.8%	COM	98422T100
—	MARINUS PHARMACEUTICALS INC	1,431,058	$6,926	0.8%	$15.48	—	COM NEW	56854Q200
—	ARYA SCIENCES ACQU CORP IV	700,000	$6,867	0.8%	$10.47	—	CL A	G31659108
IVVD	ADAGIO THERAPEUTICS INC	1,937,207	$6,354	0.7%	$37.11	-91.6%	COM	00534A102
—	SYROS PHARMACEUTICALS INC	6,264,420	$6,031	0.7%	$10.27	—	COM	87184Q107
NAUT	NAUTILUS BIOTECHNOLOGY INC	2,000,000	$5,380	0.6%	$10.83	-65.6%	COM	63909J108
—	APTINYX INC	8,891,758	$4,961	0.6%	$8.16	—	COM	03836N103
—	SOLID BIOSCIENCES INC	7,929,918	$4,882	0.6%	$7.99	—	COM	83422E105
—	PANACEA ACQUISITION CORP II	500,000	$4,880	0.6%	$10.02	—	CL A SHS	G6882C106
—	ARYA SCIENCES ACQUISITN CORP	500,000	$4,860	0.6%	$9.88	—	CLASS A ORD SHS	G31658100
—	BCLS ACQUISITION CORP	487,500	$4,826	0.6%	$11.14	—	COM CL A	G0904B105
—	FRAZIER LIFESCIENCES ACQU CO	300,000	$2,961	0.3%	$10.38	—	UNIT 12/09/2025	G3710A121
—	X4 PHARMACEUTICALS INC	3,019,540	$2,914	0.3%	$7.84	—	COM	98420X103
—	AEGLEA BIOTHERAPEUTICS INC	5,347,689	$2,701	0.3%	$5.13	—	COM	00773J103